Gault Laura 4
4 · Sage Therapeutics, Inc. · Filed Aug 7, 2024
Insider Transaction Report
Form 4
Gault Laura
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-08-05$8.96/sh−3,288$29,460→ 10,737 total - Award
Common Stock
2024-08-05+13,500→ 14,025 total
Footnotes (2)
- [F1]On February 13, 2024, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 33,750 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on August 5, 2024, resulting in the vesting of the PSUs as to 13,500 shares.
- [F2]Reflects beneficial ownership balance which includes 298 shares purchased on June 28, 2024 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.